Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization. 

Biotechnology

Medical Devices

Therapeutics

Corium

Corium's headquarters in Boston, MA, United States

Mark Sirgo

Yuemei C. (Meg)

Timothy Moore

Blythe Buchanan (she/her)

Tanya Bloker

Kevin Ostrander

John Neeley

Gary Cleary

Description

People (12)

Ruzan Avetisyan M.D., Ph.D., Mph

Jeffrey Gaffey

John Neeley

Ben Newman

Ivan Tosques

Kevin Shea

Ryan Lynch

Elizabeth McClure

Jill Cafaro

Tanya Bloker

Tracie Myers

Blythe Buchanan (she/her)